Anna-Linda Zignego

Summary

Affiliation: University of Florence
Country: Italy

Publications

  1. pmc Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment
    Cristina Stasi
    Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses MASVE, University of Florence, Florence, Italy
    J Transl Med 12:21. 2014
  2. pmc Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia
    Elisa Fognani
    Center for Systemic Manifestations of Hepatitis Viruses, MASVE, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
    PLoS ONE 8:e62965. 2013
  3. ncbi request reprint The hepatitis C virus infection as a systemic disease
    Anna Linda Zignego
    Department of Internal Medicine, Center for Systemic Manifestations of Hepatitis Viruses MASVE, University of Florence, Largo Brambilla 3, 50134, Florence, Italy
    Intern Emerg Med 7:S201-8. 2012
  4. pmc HCV and lymphoproliferation
    Anna Linda Zignego
    Center for Systemic Manifestations of Hepatitis Viruses MASVE, Department of Internal Medicine, University of Florence, 50134 Florence, Italy
    Clin Dev Immunol 2012:980942. 2012
  5. pmc Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact
    Anna Linda Zignego
    Center for Systemic Manifestations of Hepatitis Viruses MASVE, Department of Internal Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy
    J Transl Med 10:158. 2012
  6. ncbi request reprint HBV and HCV chronic infection: autoimmune manifestations and lymphoproliferation
    Anna Linda Zignego
    Center for Systemic Manifestations of Hepatitis Viruses, Department of Internal Medicine, University of Florence, Florence, Italy
    Autoimmun Rev 8:107-11. 2008
  7. ncbi request reprint Extrahepatic manifestations of hepatitis C virus infection
    Anna Linda Zignego
    Center for Systemic Manifestations of Hepatitis Viruses MASVE, Department of Internal Medicine, University of Florence, Firenze, Italy
    Clin Liver Dis 12:611-36, ix. 2008
  8. ncbi request reprint Hepatitis C virus lymphotropism: lessons from a decade of studies
    A L Zignego
    Center for Systemic Manifestations of Hepatitis Viruses MASVE, Department of Internal Medicine, University of Florence, Florence, Italy
    Dig Liver Dis 39:S38-45. 2007
  9. pmc Hepatitis C virus-related lymphoproliferative disorders: an overview
    Anna Linda Zignego
    Department of Internal Medicine, University of Florence, Viale Morgagni 85, 50134 Florence, Italy
    World J Gastroenterol 13:2467-78. 2007
  10. ncbi request reprint Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach
    A L Zignego
    Department of Internal Medicine, Medical School, Center for Research, Transfer and High Education DENOthe, Center for the Study of Systemic Manifestations of Hepatitis Viruses MaSVE, University of Florence, Florence, Italy
    Dig Liver Dis 39:2-17. 2007

Collaborators

Detail Information

Publications12

  1. pmc Assessment of liver stiffness in patients with HCV and mixed cryoglobulinemia undergoing rituximab treatment
    Cristina Stasi
    Interdepartmental Center for Systemic Manifestations of Hepatitis Viruses MASVE, University of Florence, Florence, Italy
    J Transl Med 12:21. 2014
    ..Aim of this study was to evaluate the modifications of liver stiffness following RTX treatment in HCV-related MC patients...
  2. pmc Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia
    Elisa Fognani
    Center for Systemic Manifestations of Hepatitis Viruses, MASVE, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
    PLoS ONE 8:e62965. 2013
    ..The specific, reversible downregulation of miR-26b strongly suggests the key role it plays in the pathogenesis of HCV-related LPDs and its usefulness as a biomarker of the evolution of HCV infection to these disorders...
  3. ncbi request reprint The hepatitis C virus infection as a systemic disease
    Anna Linda Zignego
    Department of Internal Medicine, Center for Systemic Manifestations of Hepatitis Viruses MASVE, University of Florence, Largo Brambilla 3, 50134, Florence, Italy
    Intern Emerg Med 7:S201-8. 2012
    ..The possibility that HCV may be eradicated following antiviral therapy is important for both the therapeutic and preventive points of view, making the HCV disease an ideal model for pathogenetic studies...
  4. pmc HCV and lymphoproliferation
    Anna Linda Zignego
    Center for Systemic Manifestations of Hepatitis Viruses MASVE, Department of Internal Medicine, University of Florence, 50134 Florence, Italy
    Clin Dev Immunol 2012:980942. 2012
    ..In this paper we describe the main hypotheses that have been proposed with the corresponding principal supporting data...
  5. pmc Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact
    Anna Linda Zignego
    Center for Systemic Manifestations of Hepatitis Viruses MASVE, Department of Internal Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy
    J Transl Med 10:158. 2012
    ..Attention will be especially focused on some conditions - liver or kidney transplantation, the use of biologic drugs and cancer chemotherapy - for which more abundant and interesting data exist...
  6. ncbi request reprint HBV and HCV chronic infection: autoimmune manifestations and lymphoproliferation
    Anna Linda Zignego
    Center for Systemic Manifestations of Hepatitis Viruses, Department of Internal Medicine, University of Florence, Florence, Italy
    Autoimmun Rev 8:107-11. 2008
    ..These characteristics have been more widely studied in the case of chronic HCV infection, where they are more evident, but they have been described also in the case of HBV infection...
  7. ncbi request reprint Extrahepatic manifestations of hepatitis C virus infection
    Anna Linda Zignego
    Center for Systemic Manifestations of Hepatitis Viruses MASVE, Department of Internal Medicine, University of Florence, Firenze, Italy
    Clin Liver Dis 12:611-36, ix. 2008
    ..This article describes the diagnosis and treatment of these diseases...
  8. ncbi request reprint Hepatitis C virus lymphotropism: lessons from a decade of studies
    A L Zignego
    Center for Systemic Manifestations of Hepatitis Viruses MASVE, Department of Internal Medicine, University of Florence, Florence, Italy
    Dig Liver Dis 39:S38-45. 2007
    ..The clinical correlates of HCV lymphotropism are potentially very numerous, including, first, its role in determining HCV-related lymphoproliferative disorders...
  9. pmc Hepatitis C virus-related lymphoproliferative disorders: an overview
    Anna Linda Zignego
    Department of Internal Medicine, University of Florence, Viale Morgagni 85, 50134 Florence, Italy
    World J Gastroenterol 13:2467-78. 2007
    ..Available pathogenetic hypotheses and suggestions about the most appropriate, currently available, therapeutic approaches will also be discussed...
  10. ncbi request reprint Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach
    A L Zignego
    Department of Internal Medicine, Medical School, Center for Research, Transfer and High Education DENOthe, Center for the Study of Systemic Manifestations of Hepatitis Viruses MaSVE, University of Florence, Florence, Italy
    Dig Liver Dis 39:2-17. 2007
    ..Special emphasis will be given to discussion of the most appropriate clinical approaches to be adopted in order to diagnose, treat (possibly prevent) and follow-up extrahepathic diseases in patients with Hepatitis C Virus infection...
  11. ncbi request reprint HCV infection, malignancy, and liver transplantation
    A L Zignego
    Transplant Proc 35:1032-3. 2003
  12. ncbi request reprint Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas
    Anna Linda Zignego
    Department of Internal Medicine, University of Florence, School of Medicine, Viale Morgagni, 85, 50134 Florence, Italy
    Ann Intern Med 137:571-80. 2002
    ..An increased prevalence of bcl-2 rearrangement (the t(14;18) translocation) has been shown in patients infected with HCV...